Sickle Cell Disease-Specific Blood Pressure Thresholds for Hypertensive Disorders of Pregnancy: A Multinational Study
Macy L. Early(Johns Hopkins University), Lydia H. Pecker(Johns Hopkins University), Ann Kinga Malinowski(Mount Sinai Hospital), Ahizechukwu C. Eke(Johns Hopkins University), Nadine Shehata(Mount Sinai Hospital), Sana Rehman(Washington University in St. Louis), Kevin H.M. Kuo(University Health Network), Marissa Solow(University Health Network)
Cited by 2
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162
Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis
|Blood|2015|129
Amnioinfusion for meconium-stained liquor in labour
|Cochrane Database of Systematic Reviews|2014|117